CervoMed (CRVO) Misses Q2 EPS by 27c
Tweet
Share
E-mailGet Alerts CRVO Hot Sheet
Join SI Premium – FREE
CervoMed (NASDAQ: CRVO) reported Q2 EPS of ($0.27). Revenue for the quarter came in at $3.29 million.
For earnings history and earnings-related data on CervoMed (CRVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Downgrades Dorman Products (DORM) to Hold
- William Blair Downgrades Tenax Therapeutics (TENX) to Market Perform
- Firms Partner With Nvidia On $500B AI Financing Deal - FT
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
